PREMAS Biotech

PREMAS Biotech

Premas delivers protein components for phase IIb clinical trials

PREMAS Biotech Products

Vision & Mission

We aspire to be a partner of choice in providing

integrated discovery and development solutions

for your protein and biotherapeutic needs.

PREMAS Biotech Research Services

Research Services

A diverse range of expertise
lead by capable individuals
Download our Service Brochure

Who are we!


Premas is a custom protein research and manufacturing organization, which delivers end-to-end integrated discovery and development solutions to leading pharmaceutical and biotech companies. Our capabilities include handling difficult to express and difficult to purify proteins, custom manufacturing of biomolecules, process R&D, bioassay and analytical development, along with stability analysis and lyophylization.

Premas has successfully assisted top global pharma/biotech clients in generating critical reagents for their research in human healthcare, animal healthcare and agribiotech sector.

Premas has “state-of-the–art” DSIR recognized, ISO 9001:2008 certified research and manufacturing facility located near New Delhi, India. This recognition stands as testimony for the quality of our people, processes and facility. Gene-to-Protein-to-Assay has been the successful delivery model for Premas Biotech, and we have delivered over 500 different types of proteins, along with their assays and analytics.

Premas has fully fitted out facilities for large scale manufacturing up to 1400 L in bacteria, yeast and allied systems. For mammalian and baculovirus, the scale up is up to 100 L at a go.

Our supply chain team ensures your valuable proteins and assays reach you timely & in proper conditions. We have tie ups with international companies such as World Courier and Fed-Ex for dry ice, blue ice and room temperature shipments. The shipments are monitored via data loggers.

Our offerings continue to grow with our customer requirements!

Contract Research Services


  • In silico protein expression analysis
  • Cloning, expression and purification- lab scale
  • Expression and process optimization
  • Analytical development
  • Reporter gene assay development
  • Stability studies
  • Formulation and lyophilization

Contract Biomanufacturing Services

  • Recombinant protein production
  • Antibody production
  • Recombinant vaccine development & production
  • Upstream & downstream process development
  • Scale Up studies
  • Analytical development
  • Biochemical and cell based assay development
  • Reporter gene assay development
  • Formulation and lyophilization
  • Technology transfer

Latest UpdatesLatest Updates

  • Premas' First-Quarter 2014-15 Project Highlights
    • Delivered protein components for Phase IIb Clinical trial for Oral Insulin.

    • Concept to product for a Vaccine carrier including process development for upscaling

    • Delivered recombinant Mabs for therapeutic implications.

    • ER Membrane preps for in vitro assays for HTS compound screening
  • Premas @ PEGS 2015
    Meet us @ Booth # 209

    Keynote Presentation:
    Day 1: May 4, 2015
    11:50 Expression of Difficult-to-Express Proteins via Novel in silico Software Coupled with Multi-Modal Expression Screen
    Prabuddha K. Kundu, Ph.D., Co-Founder & Executive Director, Premas Biotech Pvt Ltd

    Expression of difficult-to-express proteins is rigorous, fraught with failures and frequent delays. We have developed a multi-modal expression tool coupled with an in silico guidance software. We are able to express successfully multi-membrane pass proteins, immuno-modulatory proteins, rCRM197, viral vaccine candidates, etc in less than 8 weeks to generate the data.